The advanced orthopedic technologies, implants, and regenerative products market has seen considerable growth due to a variety of factors.
•The market size for advanced orthopedic technologies, implants, and regenerative products has been experiencing robust growth recently. It's projected to expand from $66.4 billion in 2024 to $70.12 billion in 2025 with a compound annual growth rate (CAGR) of 5.6%.
The phenomenal growth over the historic period can be related to the aging population, increased cases of orthopedic conditions, joint replacement surgeries, favorable reimbursement policies, and the global expansion of orthopedic markets.
The advanced orthopedic technologies, implants, and regenerative products market is expected to maintain its strong growth trajectory in upcoming years.
• In the near future, the market size for advanced orthopedic technologies, implants, and regenerative products is projected to experience substantial growth. By 2029, it is predicted to reach $90.85 billion, growing at a compound annual growth rate (CAGR) of 6.7%.
This growth during the forecast period can be credited to developments in nano-scale orthopedic treatments, patient-specific instrumentation, precision medicine in orthopedics, value-based healthcare, and the expansion of ambulatory surgery centers (ascs). Key trends to watch during this forecast period include advances in regenerative medicine, robotics-assisted surgery, 3d printing technology, improvements in biomaterials, smart and biodegradable implants, and the merging of augmented reality (ar) and virtual reality (vr). There is also a growing trend of collaborations with data analytics companies and a focus on sustainability within orthopedics.
An escalating occurrence of orthopedic ailments is anticipated to fuel the expansion of the advanced orthopedic technologies, implants, and regenerative products market. Orthopedic disorders refer to issues impacting the musculoskeletal system, which comprises the bones, joints, muscles, tendons, ligaments, and cartilage. As the number of such diseases multiply, so does the demand for advanced orthopedic technologies, implants, and regenerative products, which are pivotal for diagnosing, treating and managing these diseases and their symptoms. For instance, the National Center for Health Statistics report from February 2024 indicated that in 2022, 18.9% of adults aged 18 years and above had been diagnosed with arthritis after adjusting for age. Women (21.5%) were higher affected than men (16.1%). With increasing age, the prevalence also grew, from 3.6% in adults aged 18–34 to 53.9% in those aged 75 and above. Hence, the rising occurrence of orthopedic disorders stimulates the growth of the advanced orthopedic technologies, implants, and regenerative products market.
The advanced orthopedic technologies, implants, and regenerative products market covered in this report is segmented –
1) By Type: Implants, Regenerative Products
2) By Product: Orthopedic Fixation Devices, Orthopedic Replacement Devices, Orthopedic Prosthetics, Orthopedic Braces And Support Products, Spinal Implants And Surgical Devices, Arthroscopy Instruments, Orth Biologics, Bone Graft Substitutes
3) By Site: Hip And Pelvis, Foot And Ankle, Knee And Thigh, Hand And Wrist, Shoulder, Arm And Elbow, Spine, Craniomaxillofacial
4) By Application: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other Applications
Subsegments:
1) By Implants: Joint Implants, Bone Implants, Spine Implants
2) By Regenerative Products: Stem Cell Products, Platelet-Rich Plasma (PRP) Products, Bone Graft Substitutes
The growth and development of innovative technologies is a significant trend emerging in the market for advanced orthopedic technologies, implants, and regenerative products. Major industry players within this market are employing these new technologies in order to stay competitive. For instance, in January 2023, Orthofix Medical Inc., a company based in the US that offers spinal, orthopedic, bone growth, and motion preservation products, introduced the Mariner deformity pedicle screw system. The main aim of this system is to provide an all-inclusive solution that fulfills clinical objectives and broadens the modular platform of the Mariner family. It merges biologics and 7-D Flash navigation with the accuracy of machine vision and segmental registration. The Mariner system takes full advantage of Mariner's dependable modular technology to provide a diverse array of implants while simultaneously reducing the typical number of surgical trays required for deformity surgery.
Major companies operating in the advanced orthopedic technologies
• implants
• and regenerative products market include:
• Johnson & Johnson
• Medtronic PLC
• Stryker Corporation
• B Braun Medical Inc.
• Zimmer Biomet Holdings Inc.
• Smith & Nephew PLC
• Arthrex Inc.
• Integra LifeSciences Holdings Corporation
• Lepu Medical Technology Co Ltd.
• NuVasive Inc.
• CONMED Corporation
• Globus Medical Inc.
• Wright Medical Group N.V.
• Bioventus LLC
• Orthofix Medical Inc.
• Alphatec Holdings Inc.
• Acumed LLC
• MiMedx Group Inc.
• Exactech Inc.
• Anika Therapeutics Inc.
• DJO Global Inc.
• Misonix Inc.
• Osiris Therapeutics Inc.
• Bacterin International Holdings Inc.
• Cerapedics Inc.
• Histogenics Corporation
• Kuros Biosciences AG
• Life Spine Inc.
• Aurora Spine Corporation
• Camber Spine Technologies LLC.
North America was the largest region in the advanced orthopedic technologies, implants, and regenerative products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced orthopedic technologies, implants, and regenerative products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa